Ranked Importance of Visual Function Outcome Measures in Choroideremia Clinical Trials
Clinical trials in choroideremia for early and mid-stage disease would be justified in moving away from using standard BCVA as a clinical trial outcome measure as we have shown its sensitivity to be relatively low compared to microperimetry. We have also demonstrated how functional measures rank in terms of importance.
Authors
- Amandeep S. Josan (ORCID: https://orcid.org/0000-0003-1808-6546)
- Laura J. Taylor (ORCID: https://orcid.org/0000-0001-7072-0853)
- Robert E. MacLaren (ORCID: https://orcid.org/0000-0002-3096-4682)
- Jasmina Cehajic‐Kapetanovic (ORCID: https://orcid.org/0000-0002-9956-6412)
- Kanmin Xue (ORCID: https://orcid.org/0000-0003-0065-9131)
Institutions
- University of Oxford (GB)
- Oxford BioMedica (United Kingdom) (GB)
- Oxford University Hospitals NHS Trust (GB)
Publication Details
- Journal
- Investigative Ophthalmology & Visual Science
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1167/iovs.65.13.58
- Citations
- 2
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.08
Funders
- National Institute for Health and Care Research